文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后良好预后的多模态预测:一项队列研究

Multimodal Prediction of Favorable Outcome After Cardiac Arrest: A Cohort Study.
PubMed 文献 · Crit Care Med · 2023-03-23
一句话结论多模态评分(早期EEG非高度恶性、EEG反应性/连续性、NSE≤41 µg/L、72小时FOUR≥5)≥4/6分预测心脏骤停后3个月良好神经预后,灵敏度97.5%。

该研究为回顾性分析前瞻性收集的数据(2016年1月至2021年6月),纳入两家学术医院499例心脏骤停后昏迷成人,无干预。研究提取心脏骤停变量、临床检查(72小时FOUR评分、早期肌阵挛)、EEG(反应性、连续性、癫痫样特征及预设高度恶性模式)、体感诱发电位、定量瞳孔测量和血清NSE,以3个月CPC 1-2为良好预后。通过多变量有序逻辑回归、ROC曲线和交叉验证构建含6个模态(各1分)的多模态评分,≥4/6分时灵敏度97.5%(95%CI 92.9-99.5%)、准确率77.5%(95%CI 72.7-81.8%)、AUC 0.88(95%CI 0.85-0.91),验证队列表现相似。作者结论认为该评分可识别3个月时达到功能独立的心脏骤停后早期昏迷幸存者。

要点

  • 多模态评分≥4/6分预测心脏骤停后3个月CPC 1-2的灵敏度97.5%(95%CI 92.9-99.5%),准确率77.5%(95%CI 72.7-81.8%)。
  • 评分包含6项各1分:早期(12-36小时)EEG非高度恶性、早期EEG背景反应性、晚期(36-72小时)EEG背景反应性和连续性、48小时内峰值血清NSE≤41 µg/L、72小时FOUR评分≥5。
  • 评分AUC为0.88(95%CI 0.85-0.91),在验证队列中表现相似。
  • 所有评分项目均在72小时内可获得,便于早期评估昏迷心脏骤停幸存者的良好预后。

适用人群与场景

  • 两家学术医院(瑞士洛桑大学中心医院、美国波士顿布莱根妇女医院)心脏骤停后收入院并处于昏迷的成人,连续纳入499例。
  • 研究为回顾性分析前瞻性收集的数据(2016年1月至2021年6月),无干预。

诊断标准与关键阈值

  • 良好神经预后定义为3个月时脑功能分类(CPC)1或2。
  • 多模态评分共6分(每项1分):1)早期(12-36小时)EEG非高度恶性;2)早期EEG背景反应性;3)晚期(36-72小时)EEG背景反应性;4)晚期(36-72小时)EEG连续性;5)48小时内峰值血清NSE≤41 µg/L;6)72小时FOUR评分≥5。
  • 评分≥4/6分用于识别良好预后,灵敏度97.5%(95%CI 92.9-99.5%),准确率77.5%(95%CI 72.7-81.8%),AUC 0.88(95%CI 0.85-0.91)。

研究设计与关键结果

  • 研究类型:回顾性分析前瞻性收集的数据(2016年1月至2021年6月),两家学术医院,499例心脏骤停后昏迷成人,无干预。
  • 主要终点:3个月CPC 1-2为良好预后;多模态评分≥4/6分时灵敏度97.5%(95%CI 92.9-99.5%),准确率77.5%(95%CI 72.7-81.8%),AUC 0.88(95%CI 0.85-0.91)。
  • 评分在验证队列中表现相似。
  • 评分项目包括临床、EEG和生物学指标,均在72小时内可获得。

证据类型、等级与局限

  • 证据类型:回顾性分析前瞻性收集数据的队列研究,并进行了外部验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该多模态评分在识别早期昏迷心脏骤停幸存者中表现出高性能,这些患者将在3个月时达到功能独立。
  • 评分项目均在72小时内可获得,可能有助于早期评估良好预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Prognostic guidelines after cardiac arrest (CA) focus on unfavorable outcome prediction; favorable outcome prognostication received less attention. Our aim was to identify favorable outcome predictors and combine them into a multimodal model.

DESIGN: Retrospective analysis of prospectively collected data (January 2016 to June 2021).

SETTING: Two academic hospitals (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Brigham and Women's Hospital, Boston, MA).

PATIENTS: Four hundred ninety-nine consecutive comatose adults admitted after CA.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: CA variables (initial rhythm, time to return of spontaneous circulation), clinical examination (Full Outline of UnResponsiveness [FOUR] score at 72 hr, early myoclonus), electroencephalography (EEG) (reactivity, continuity, epileptiform features, and prespecified highly malignant patterns), somatosensory-evoked potentials, quantified pupillometry, and serum neuron-specific enolase (NSE) were retrieved. Neurologic outcome was assessed at 3 months using Cerebral Performance Category (CPC); 1 and 2 were considered as favorable outcome. Predictive performance of each variable toward favorable outcomes were calculated, and most discriminant items were combined to obtain a multimodal prognostic score, using multivariable ordinal logistic regression, receiving operator characteristic curves, and cross-validation. Our analysis identified a prognostic score including six modalities (1 point each): 1) early (12-36 hr) EEG not highly malignant, 2) early EEG background reactivity, 3) late (36-72 hr) EEG background reactivity and 4) continuity, 5) peak serum NSE within 48 hours less than or equal to 41 µg/L, and 6) FOUR score greater than or equal to 5 at 72 hours. At greater than or equal to 4 out of 6 points, sensitivity for CPC 1-2 was 97.5% (95% CI, 92.9-99.5%) and accuracy was 77.5% (95% CI, 72.7-81.8%); area under the curve was 0.88 (95% CI, 0.85-0.91). The score showed similar performances in the validation cohort.

CONCLUSIONS: This study describes and externally validates a multimodal score, including clinical, EEG and biological items available within 72 hours, showing a high performance in identifying early comatose CA survivors who will reach functional independence at 3 months.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Vanat A, Lee JW, Elkhider H, et al. Multimodal Prediction of Favorable Outcome After Cardiac Arrest: A Cohort Study. Crit Care Med. 2023. PMID: 36951448. doi:10.1097/CCM.0000000000005841

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。